Background: The outcomes of psychological therapies for anxiety and depression vary across
Introduction:
Depression and anxiety disorders are the most prevalent mental health disorders, with lifetime prevalence rates approaching 17% and 29% for major depression and anxiety disorders respectively (Kessler et al., 2005) . Psychological interventions are a recommended treatment option, but as outcomes vary across patients, there is a need to consider a more personalised approach to treatment selection. An aim of such an approach is to tailor treatments based on key patient variables, thereby identifying which treatment will provide the best outcome for a particular patient (Goldberger & Buxton, 2013) . The successful implementation of such a tailored treatment strategy could also lead to better outcomes and increased cost-effective use of resources.
Research aiming to predict response to treatment for depression and anxiety has been growing.
Researchers have adopted a wide array of methods for making predictions, including neuroimaging data (Siegle, Carter & Thase, 2006) and genetic markers (Papakostas & Fava, 2008) . However, despite some progress, these have thus far not demonstrated clinical utility and some approaches (e.g. neuroimaging) may not be feasible for routine use (Evans, Dougherty, Pollack & Rauch, 2006) .
Using patient information collected as part of routine assessment procedures may have significant potential to aid treatment selection decisions for the clinician and the patient in a way that is realisable at scale across a range of healthcare settings. Systematic reviews have identified a range of individual patient factors that may predict response to both psychological and pharmacological interventions in depression and anxiety disorders, including variables such as initial symptom severity, relationship status, age, and gender (Mululo, De Menezes, Vigne & Fontenelle, 2012; Cuijpers, Van Straten, Warmerdam, & Smits, 2008) .
Decision support algorithms are increasingly used throughout health care (Sheehan & Sherman, 2012) , and although their uptake in mental health has been slower, decision support systems are being piloted (Botella, Moragrega, Bańos & García-Palacios, 2011; Bowles, et al., 2014) . Wallace, Frank and Kraemer (2013) created a single combined moderator value from weightings of key patient variables, and used this moderator to predict whether pharmacological or psychological treatment would be more effective for a given patient. A significant difference was found between treatment outcomes for patients scoring higher and lower on the combined moderator. DeRubeis et al., (2014) developed the 'Personalized Advantage Index' to predict the final symptom score for a given patient under both psychological and pharmacological treatments. This algorithm showed a significant advantage of one treatment type over the other for 60% of patients in the development sample.
However, both methods were developed using samples from small clinical trial populations, and require further evaluation of potential benefits in routine patient samples.
The methods used by Wallace et al. (2013) and DeRubeis et al. (2014) modelled patient variables to create two groups of patients, one responding to antidepressants and the other to psychotherapy.
However, it would be of clinical value if algorithms were developed that could predict treatment response to different psychological interventions (Roth & Fonagy, 2006) . Previous research has typically used simple regression based analyses to explore the relationship between patient variables and outcomes (Blom, Spinhoven, Hoffman, et al, 2007) , but methods that identify groups of patients with different clusters of intake characteristics may prove more powerful.
Statistical methods for identifying sub-groups of individuals within a diagnostic group such as latent class analysis (Goodman, 1974) and latent profile analysis (Lazarsfeld & Henry, 1968) , have been previously used to develop a more refined sub-grouping of patients but these studies did not investigate the implications of this for treatment response, for example, in eating disorders (Duncan et al., 2005; Wade, Crosby & Martin, 2006) and personality disorders (Bucholz et al., 2000; Fossati et al., 2001) . Further development of these methods has the potential to provide information on groups of patients seeking psychological treatment, and the differential response of these groups to psychological interventions. Identifying subgroups of patients at initial presentation could provide valuable information to clinicians and patients which could inform decisions on appropriate treatment choices in routine care.
This study used latent profile analysis on a large dataset of patients with depression and anxiety disorders receiving psychological treatment to attempt to identify statistically distinct groups of patients varying on demographic characteristics and initial symptom severity, and to explore if treatment outcomes differed between these groups.
Method:

Setting
The dataset used for this analysis was taken from two psychological treatment services in London, UK and includes all patients accepted for treatment. Both services treat individuals with depression and anxiety disorders, offering a range of evidence-based psychological interventions (IAPT, 2008; NCCMH, 2011) . The services adopted a 'stepped care' approach to treatment (IAPT, 2008) with brief interventions provided as the first step of treatment (for example Guided Self-Help, e.g. , and formal psychological therapies at the second step (such as Cognitive Behavioural Therapy). Patients may be 'stepped-up' to formal interventions if initial treatment with a brief intervention is not successful. A number of patients accepted into treatment will have had a single treatment session for advice and consultation from a clinician, and therefore provided data for only one time point.
Participants:
All patients taken into treatment between September 2008 and March 2012 who had baseline selfrated severity of symptoms information on either the Patient Health Questionnaire -9 (PHQ-9; Kroenke, Spitzer & Williams, 2001) or the Generalized Anxiety Disorder assessment (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006) , served as the discovery dataset (n=16636) for the latent profile analysis. Of the included sample, 99.78% of patients had an initial PHQ-9 score and 99.62% an initial GAD-7 score.
For the analysis of treatment outcomes, only patients from this dataset who scored above clinical caseness were included, and the cut offs used by the service are scores of 10 and 8 for patients on the PHQ-9 and GAD-7 respectively (IAPT, 2011) . Patients who received only one single treatment for advice or consultation were not included in the analysis of treatment outcomes, as these required two time-point scores on the symptom scales to calculate.
A second dataset of patients referred between April 2012 and August 2013 was used as a validation sample (n=4683).
Measures:
The patient characteristic variables included in the analysis are displayed in Table 1 , and are all collected routinely as part of the service's standardised dataset of patient information. 90% of patients entering treatment have complete data in routine care (IAPT, 2012) .
(Location Table 1 .)
Plan of analysis:
Latent profile analysis
Latent profile analysis (LPA) is an extension of latent class analysis to incorporate categorical, continuous and ordinal variables (Hagenaars & McCutcheon, 2002) . Analysis was conducted in Mplus version 7 (Muthén & Muthén, 2012) , on the initial Sept 2008 to March 2012 dataset (the discovery dataset). This discovery dataset was split into two independent samples and LPA was performed separately on these samples to allow comparison and confirmation of the profile structure in two samples.
To identify the best fitting model for the datasets, the Vuong-Lo-Medell-Rubin Likelihood Ratio test higher entropy values indicate higher accuracy in classification for the model.
As there was no prior hypothesis on the exact number of patient profile groups from the data, the analysis was conducted starting with a two profile model, and increasing the number of profiles until the VLMR-LRT became non-significant. The B-LRT was then used to confirm the K-1 model using a parametric bootstrap procedure (Asparouhov & Muthén, 2012; Geiser, 2013) . Information from the AIC, BIC and entropy values were also used to inform model fit.
This method was applied to both split samples of the discovery dataset to confirm whether the same profile structures were identified across samples.
LPA sample treatment outcomes
Following the identification of the latent profiles of patients, the next step was to determine whether there were differences in treatment outcomes between the patient profiles. Patients were allocated to the latent profile with the highest probability of profile membership. The primary outcome was the percentage of patients in each group meeting the 'recovery' criteria, which is the key performance indicator for the services and is defined as moving from clinical caseness on the PHQ-9 or GAD-7 symptom measures (or both) to below clinical caseness on both measures. In addition to this performance indicator, analysis of recovery or reliable change (Jacobsen & Traux, 1991) following intervention, clinical deterioration and dropping out of treatment were also calculated. These were defined as:
 Recovery: Scoring above clinical caseness cut-off at initial assessment on either symptom measure and scoring below the cut-off on both measures at final assessment following treatment.
 Recovery or Reliable change: Either in recovery as defined above or showing reliable improvement between initial and final assessment on both the PHQ-9 and GAD-7. Calculated using the reliable change index (Jacobsen & Traux, 1991; Evans, Magison & Barkham, 1998) .
 Clinical Deterioration: Deterioration was defined as reliable clinical change in a negative direction (increase in score) between initial and final assessment. Calculated using the reliable change index (Jacobsen & Traux, 1991; Evans, Magison & Barkham, 1998) .
 Dropout from treatment: Defined as either dropping out of treatment, or as declining treatment after two or more treatment sessions by the service.
These outcomes were then compared across patient profile groups. A series of logistic regression analyses were performed, entering only two profiles on each occasion as the independent variable (for example, profile 1 vs profile 2) to allow a direct comparison of the odds ratio of each outcome between the profiles. Analysis was conducted using STATA 12 (StataCorp, 2011) .
Validation sample treatment outcomes
After calculating the treatment outcomes across the groups in the discovery sample, the validation sample (patients from April 2012 to August 2013) was used to test whether the predictive relationships between intake LPA patient profiles and outcome were maintained in a second independent sample of patients attending the same services.
Treatment outcomes by intensity of intervention.
Following the comparison of outcomes between the discovery and validation datasets by latent profiles, a comparison of outcomes between individuals receiving brief interventions or formal psychological therapies was performed. For this analysis, the discovery and validation included samples were combined. As the focus of this analysis was difference between intervention intensities, only patients who were treated in just one intensity of intervention were included; patients who were stepped up during the course of treatment were excluded as they would have received both interventions.
The likelihood of achieving positive outcomes following treatment was compared between the two intensities of intervention for each latent profile, and logistic regression analysis was performed with the level of intervention as the independent variable for each latent profile.
Results:
Latent profile analysis
A random 50% split of the development sample resulted in two samples of n=8321 (Discovery sample 1a) and n=8315 patients (Discovery sample 1b). Model comparison statistics are presented in Appendix 1. The LPA for discovery sample 1a yielded significant p-values on the VLMR-LRT comparing successive models, from a two-profile solution to an eight-profile solution (p=0.0057 at the eight-profile model), as well as decreasing AIC and BIC values. Although the BIC and AIC values were slightly lower for the nine-profile solution, the VLMR-LRT produced a non-significant p-value (p=0.3551) suggesting that increasing the number of profiles was not a better fit for the data (Asparouhov & Muthén, 2012; Geiser, 2013) . The entropy value was also higher for the eight-profile solution suggesting higher classification accuracy, and therefore the VLMR-LRT indicated eight-profile solution was preferred, in line with previous latent profile analyses (Rajendran, et al., 2015; Merz & Roesch, 2011) .B-LRT was performed on the eight-profile solution, with a significant finding between the eight and seven profile models (p<0.0001).
The LPA for discovery sample 1b also yielded significant increases in model fit according to the VLMR-LRT up to the eight-profile model (p<0.0001 for the eight-profile model compared to the sevenprofile model) with decreasing and AIC and BIC values, and again the nine-profile model produced a non-significant VLMR-LRT p-value (p=0.940). The B-LRT confirmed a significant p-value for the eightprofile model compared to the seven-profile model (p<0.0001).
Following confirmation of an eight-profile model structure from the two independent split samples, the dataset was re-combined, and the same method of LPA applied on the full sample of n=16636 to generate probabilities of profile membership for each patient in the sample. As before, VLMR-LRT showed a significant p-value up to the nine-profile model (p=0.699) with the eight profile model selected and probability of profile membership assigned to each case in the analysis.
(Location Table 2.)
Descriptive statistics for the full sample and the distribution of patient characteristics for each LP are displayed in Table 2 (a graphical representation of the profiles and description of each profile is available in Appendix 2). Comparing each patient profile to both the full sample means and distribution and the other profiles provides an understanding of the characteristics of each group of patients. For example, latent profile 1 (LP1) is a younger, lower symptom severity group (on both PHQ-9 and GAD-7) and tends to score low the phobia scale, and is less likely to be on public welfare benefits and medication compared to the overall sample. The LP2 has a similar age, gender, and ethnic group distribution to LP1, but with higher symptom severity and lower functioning, as well as having a higher probability of phobia. LP7 has the highest intake symptom severity (means of 23 and 19 on the PHQ and GAD), with a high probability of being on public welfare benefits, prescribed medication, and phobia symptoms. There was a large variation in the size of the patient profiles, with LP3 and LP4 having a smaller share of the population (3.1% and 4.1%) compared to LP2 and LP8 (22.7% and 22.1%).
Treatment outcomes
The next step was to test whether the LPA groups were predictive of response to treatment. Of the n=16636 patients included in the LPA, n=2691 (16.18%) scored below clinical caseness on both symptom measures, and n=3252 patients (19.55%) only received a single treatment session. This resulted in n=10693 patients included in the analysis of treatment outcomes.
Full tabulation of all outcomes by LP are presented in the first section of Table 3 , and odds ratios (OR) from logistic regression analyses between profiles for each outcome are presented in Appendix 3. Inspection of the recovery outcomes shows a large variation between the patient profiles. For example LP1 has the highest recovery rate across the profiles, with 74% of patients in recovery at endpoint after treatment. The worst outcomes were for LP7, with just 15% in recovery, indicating that recovery is 4.9 times more likely in LP1 compared to LP7. Logistic regression comparing these two profiles showed the odds of recovery are 16.75 higher for patients in LP1 compared to those in LP7 (OR=16.75, 95% CI=13.4-20.9, p<0.001). As expected, when outcome is defined by the rates of reliable change or recovery the picture improves somewhat, with positive outcomes for LP7 increasing to 22% reliable change or recovery following treatment. Figure 1 compares the recovery alone against the reliable change or recovery outcomes across profiles. LP5 and LP8 display the biggest differences between these two outcomes, and it might be that different outcomes are to be expected for certain profiles.
Less variation was found between patient profiles for treatment dropout compared to recovery.
Nevertheless, the LPA groupings still robustly distinguish cases that subsequently dropped out, with, for example, 2.35 times more drop outs in LP8 versus LP3 (17% versus 40%; OR=3.31, 95% CI=1.7-6.3, p<0.001). Although the rates of clinical deterioration were low in the sample overall (9% for the full sample), there was significant variation between profiles, for example 4 times greater probability of deterioration in LP6 compared to LP7 (5% versus 20%; OR=4.59, 95% CI=3.5-6.0, p<0.001).
(Location figure 1) (Location Table 3 .)
Validation sample treatment outcomes
The second dataset of patients, referred to the service between April 2012 and April 2013 included n=4683 patients. Membership to each latent profile was calculated using the posterior probabilities of group membership from the original LPA. This calculation provides each patient in the new sample a probability of membership to each latent profile using their intake patient variables. Outcomes for the validation sample are displayed in the second section of Table 3 . By comparing the outcomes for each patient profile from the discovery sample to this validation sample shows remarkably similar probabilities of each outcome. For example, LP1 have the highest probability of recovery at 76% and LP7 the lowest with 13% recovery follow treatment. LP6 have the highest probability of deterioration (20%) and LP8 are the most likely to drop out (46%). The only major difference between recovery and reliable change rates between the discovery and validation samples, displayed in Figure 1 , appears to be a slightly reduced percentage of patients in LP5 who achieved recovery or reliable change (42% discovery sample vs 35% in the validation sample). The major differences in prediction of treatment dropout and clinical deterioration between the two samples were for LP3, but the number of patients in the second dataset meeting the inclusion criteria for this patient profile was very low (just n=29 patients included in the analysis) making the results difficult to interpret.
Intensity of intervention
The analyses above present the variations outcomes between latent profiles following any treatment from the services. However, it is also of interest to explore whether there are differences in outcome between the different intensities of treatment within latent profiles. To explore if there were any differences in symptom severity of patients receiving different treatments the mean initial PHQ-9 and GAD-7 score for patients receiving brief or formal interventions was compared within each LP (Appendix 4). Independent samples t-tests show that the only differences in mean symptom severity scores were for LPs 1 and 2. Mean PHQ-9 scores were significantly higher in the formal intervention group for LP1, although the GAD-7 score was significantly higher for patients receiving brief interventions. For LP2, mean PHQ-9 score was significantly lower for patients receiving formal psychological therapies, whereas the initial GAD-7 score was higher in this group compared to patients receiving brief interventions. Of course a range of variables other than scores of a symptom severity scale influence the presentation and course of a mental disorder.
The first section of Table 4 displays the percentage of patients who recovered after receiving either brief interventions or formal psychological therapy only, as well as the odds ratio and p-value for recovery between the two interventions. Significant ORs (p<0.05) were found for LP2 (OR=1.32, 95% CI=1.13-1.54, p=0.001), LP6 (OR=1.39, 95% CI=1.11-1.75, p=0.004) and LP7 (OR=1.66, 95% CI=1.24-2.22, p=0.001), with increased odds of recovery for individuals in these profiles receiving formal interventions instead of more brief interventions.
(Location Table 4 .)
The second section of Table 4 (Location Table 5 .)
The second section of Table 5 Although clinical deterioration was more likely following formal interventions, LP7 was the only profile where this difference was significant. Treatment dropout was significantly more likely during brief interventions for five of the eight patient profiles when compared to formal interventions.
Discussion:
LPA identified eight statistically reliable groups of patients in receipt of psychological treatment and the profile structure was replicated in two independent samples of over 8000 patients each.
Importantly, the eight groups showed significant variation in outcomes following treatment. This variance in outcomes between latent profiles suggests that identification of these groups at initial assessment can provide reliable information about patients' likely response to treatment, which may be of value when making informed treatment selection decisions. The variation in groups was replicated with an independent validation sample, revealing that the predictive associations between latent profile and treatment outcomes were very similar to the findings from the first analysis.
The latent profiles identified groups of patients attending services for psychological treatment, who share a set of common characteristics within each group and which is associated with different treatment outcomes. For example, the typical characteristics of patients in LP1 are relatively low levels of depression and anxiety symptom severity, fewer phobic symptoms and relatively high levels of functioning compared to the full sample averages. These patients have a very high likelihood of a positive outcome following treatment (74%) relative to the full dataset (40%), and therefore may be patients for who for brief interventions are likely to be sufficient to achieve a good outcome. It should be noted that 31% of LP1 patients received a formal intervention and considering the high probability of recovery from brief interventions, this might represent over use of healthcare resource and an unnecessary burden for patients. LP1 and LP3 share a number of similar characteristics, such as low levels of symptom severity and unlikely to be in receipt of welfare benefits, be prescribed medication or have phobic symptoms. However, the mean age of LP3 is twice that of LP1 (33 compared to 67), as well as being less likely to be from a non-white ethnic group (11% compared to 17%), but these differences appear to have little impact on the likelihood of recovery which is very similar for both profiles. As 45% of LP3 patients were in receipt of formal interventions, this again may reflect an unnecessary use of service resource.
Considering patients with poorer outcomes, LP7 show relatively high levels of both depression and anxiety symptoms which may account for the high proportion prescribed psychotropic medication (74%) compared the full dataset (39%). These characteristics may also contribute to the low number in work (93% were in receipt of welfare benefits). The outcomes for this group are relatively poor for both brief and formal interventions, which may imply that alternative treatment options should be considered. However, the significant difference in recovery between brief and formal interventions suggests that if they were to be treated in the services included in this study then a formal intervention should be considered. The outcomes for recovery or reliable change also suggest that formal interventions might also be considered as the initial treatment for patients in LP8, as the outcomes for brief interventions were significantly lower for this profile of patients.
Identifying patients at risk of deterioration is important as it may reduce the likelihood of ineffective or harmful treatments being offered. For example, the deterioration rates for LP6 were four times higher (20%) compared to LP7 (5%), and more than double the mean deterioration for the whole sample (9%). As the probability of recovery for this profile at 46% was similar to the overall recovery rate for the whole sample, this suggests that if treatment were to be offered to this group of patients then a number of additional factors may be worth considering, such as offering formal interventions (there was a significant difference between brief and formal interventions), the use of additional interventions (for example, medication) and careful sessional monitoring of progress. Similarly, as the probability of drop out is very high in brief interventions for LP7 and LP8 (39%), and this information could be used by clinicians either to consider treatment retention as part of the intervention goals, or formal interventions as the initial treatment to reduce the incidence of drop out.
Important clinical information may be derived not only from membership to a single profile, but also which additional profiles the patient shares characteristics with. LPA provides a probability that each case (patient) is a member of each group, with the case allocated to the group to which they have the highest probability of belonging. There will be a range of probabilities of group membership within each profile, and different members of a LP will have a probability of membership from 100% to below 50%. A patient with a probability of less than 100% for a particular group will therefore have a probability of being in other profiles as well as their allocated patient profile. For example, a patient may have a number of characteristics that indicate a 70% probability of being in LP6, and 30% for LP7, which could be viewed as their secondary profile. Identification of these secondary profiles is straightforward using the posterior probability calculation, and may provide additional information, for example, of the risk of deterioration or recovery to inform a clinical decision.
Although previous prediction models have reported significant differences in treatment response (Wallace et al., 2013; DeRubeis et al., 2014) , the findings were drawn from small, highly selected trial populations. In contrast, our study has used data from a large sample in routine clinical practice and validated the findings in an additional sample. The ability of the latent profile approach to identify differences in deterioration rates is also important as previous studies (Hannan, et al., 2005) have indicated that clinicians may be poor at identifying patients who are likely to deteriorate. Latent profile methods using easily available patient variables offers the possibility of readily identifying sub-groups with a clinical population who are at risk of not improving or may even deteriorate, and for whom formal intervention should be considered as an initial treatment.
Limitations:
One limitation of this study is that the eight-profile structure was identified in a large sample of patients from two services in the United Kingdom healthcare system, and it is possible that services in other healthcare systems may have different profiles of patients. The profile structure identified in this analysis should be further explored in datasets from additional services. If there is some variation in profile structure then this could be used to tailor profiles to represent the local population of patients attending the services.
All patient characteristic variables used in this analysis are easily obtainable as part of routine data collection. However, the dataset does not include a number of patient variables, including diagnosis, that might be expected to influence treatment outcomes as well as other variables such as relationship status and response to previous treatment (Mululo, De Menezes, Vigne & Fontenelle, 2012) . Such factors may be important in further refining the patient profiles and predicting treatment response, but may also contribute to existing treatment selection decisions made by clinicians.
Although there were no systematic differences in initial symptom severity scores between patients who received brief interventions or formal psychological therapies within each LP, clinicians will likely have considered additional patient factors when allocating patients to higher intensity treatments.
Clinical and research implications:
There is potential for the profiles identified in this study to be made available to clinicians, for example by converting the posterior probability calculations used in this analysis into an algorithm that could be hosted either through local clinical data management systems or through an App on a mobile phone or tablet. The information obtained on new patients could be used to inform a discussion between clinician and patients on the appropriate choice of treatment. Aggregation of the data derived from the algorithm could also inform clinic and service audits and evaluations. These approaches should be the subject of future research which explores their feasibility and utility in supporting clinicians and patients to aid decisions on treatment selection (including both psychological and pharmacological treatment). The use of additional information, such as diagnosis or previous treatment response could also lead to refinements to the latent profile analysis and associated algorithms to further increase their utility. This may improve outcomes for both patients and services, and contribute to a more effective and efficient healthcare system.
Conclusions:
The findings from this analysis suggest that latent profile analysis may provide a robust method of grouping patients that is predictive of treatment outcome in routine psychological care. The outcomes for each profile following either brief interventions or formal psychological interventions suggest, for some profiles of patients, that higher intensity treatment is more likely to yield positive outcomes, whereas for other groups outcomes between intensities of intervention were very similar. Developing an algorithm using the posterior probabilities of this LPA, and by providing this information to clinicians could aid decision making around treatment selection and increase the likelihood of beneficial experiences from treatment (for example, more intensive treatment offered initially), whilst reducing potentially harmful experiences (refer patient to alternative treatment, or even services).
Replication of this work in large datasets drawn from other psychological treatment services will be important in establishing the generalisability of this method. 
